Parkinson's Disease prescription
Item
Identifier: MSS 392
Content Description
This collection consists of a prescription for Parkinson's disease treatment, in French, written in Paris on 4 May 1877, presumably by Dr. J. M. Charcot. The name "Dr. Seguin" also appears. A typescript copy, translated into English, is available.
Dates
- 4 May 1877
Biographical / Historical
Jean-Martin Charcot was born in Paris, France, late in 1825. Although he was a nineteenth century scientist, his influence carried on into the next century, especially in the work of some of his well-known students.
He was a professor at the University of Paris for 33 years, and in 1862 he began an association with Paris's Salpêtrière Hospital that lasted throughout his life, ultimately becoming director of the hospital. Charcot was known as an excellent medical teacher, and he attracted students from all over Europe. His focus turned to neurology, and he is called by some the founder of modern neurology. In 1882, he established a neurological clinic at the Salpêtrière that was unique in Europe.
The first clear medical description of Parkinson disease was written in 1817 by James Parkinson. In the mid-1800s, Jean-Martin Charcot was particularly influential in refining and expanding this early description and in disseminating information internationally about Parkinson's disease. He separated Parkinson's disease from multiple sclerosis and other disorders characterized by tremor, and he recognized cases that later would likely be classified among the Parkinsonism-plus syndromes. Early treatments of Parkinson's disease were based on empirical observation, and anticholinergic drugs were used as early as the nineteenth century.
Charcot took an interest in the malady then called hysteria. It seemed to be a mental disorder with physical manifestations, of immediate interest to a neurologist. He believed that hysteria was the result of a weak neurological system which was hereditary. It could be set off by a traumatic event like an accident, but was then progressive and irreversible. To study the hysterics under his care, he learned the technique of hypnosis and soon became a master of the relatively new "science." Charcot believed that a hypnotized state was very similar to a bout of hysteria, and so he hypnotized his patients in order to induce and study their symptoms. He did not plan to cure them by hypnosis -- in fact, he felt that only hysterics could be hypnotized. He would hypnotize patients for groups of students and others, gaining the nickname "the Napoleon of the neuroses."
Among Charcot's students were Alfred Binet, Pierre Janet, and Sigmund Freud. They were impressed with Charcot and went on to use hypnosis in their own way, but disagreed with their teacher that it was a neurological phenomenon. They considered the hypnotic state a psychological one.
Charcot's work encompassed other aspects of neurology as well. He was first to describe the degeneration of ligaments and joint surfaces due to lack of use or control, now called Charcot's joint. He did research to determine the parts of the brain responsible for specific nerve functions and discovered the importance of small arteries in cerebral hemorrhage.
He died in 1893 in Morvan, France.
Sources: “Jean-Marie Charcot.” A Science Odyssey: People and Discoveries. WGBH PBS. 1998. Accessed 19 June 2018. http://www.pbs.org/wgbh/aso/databank/entries/bhchar.html
Goetz, Christopher G. “The History of Parkinson's Disease: Early Clinical Descriptions and Neurological Therapies.” Cold Spring Harb Perspect Med 1, no. 1 (September 2001): 1-15. Accessed 19 June 2018. http://perspectivesinmedicine.cshlp.org/content/1/1/a008862.full
He was a professor at the University of Paris for 33 years, and in 1862 he began an association with Paris's Salpêtrière Hospital that lasted throughout his life, ultimately becoming director of the hospital. Charcot was known as an excellent medical teacher, and he attracted students from all over Europe. His focus turned to neurology, and he is called by some the founder of modern neurology. In 1882, he established a neurological clinic at the Salpêtrière that was unique in Europe.
The first clear medical description of Parkinson disease was written in 1817 by James Parkinson. In the mid-1800s, Jean-Martin Charcot was particularly influential in refining and expanding this early description and in disseminating information internationally about Parkinson's disease. He separated Parkinson's disease from multiple sclerosis and other disorders characterized by tremor, and he recognized cases that later would likely be classified among the Parkinsonism-plus syndromes. Early treatments of Parkinson's disease were based on empirical observation, and anticholinergic drugs were used as early as the nineteenth century.
Charcot took an interest in the malady then called hysteria. It seemed to be a mental disorder with physical manifestations, of immediate interest to a neurologist. He believed that hysteria was the result of a weak neurological system which was hereditary. It could be set off by a traumatic event like an accident, but was then progressive and irreversible. To study the hysterics under his care, he learned the technique of hypnosis and soon became a master of the relatively new "science." Charcot believed that a hypnotized state was very similar to a bout of hysteria, and so he hypnotized his patients in order to induce and study their symptoms. He did not plan to cure them by hypnosis -- in fact, he felt that only hysterics could be hypnotized. He would hypnotize patients for groups of students and others, gaining the nickname "the Napoleon of the neuroses."
Among Charcot's students were Alfred Binet, Pierre Janet, and Sigmund Freud. They were impressed with Charcot and went on to use hypnosis in their own way, but disagreed with their teacher that it was a neurological phenomenon. They considered the hypnotic state a psychological one.
Charcot's work encompassed other aspects of neurology as well. He was first to describe the degeneration of ligaments and joint surfaces due to lack of use or control, now called Charcot's joint. He did research to determine the parts of the brain responsible for specific nerve functions and discovered the importance of small arteries in cerebral hemorrhage.
He died in 1893 in Morvan, France.
Sources: “Jean-Marie Charcot.” A Science Odyssey: People and Discoveries. WGBH PBS. 1998. Accessed 19 June 2018. http://www.pbs.org/wgbh/aso/databank/entries/bhchar.html
Goetz, Christopher G. “The History of Parkinson's Disease: Early Clinical Descriptions and Neurological Therapies.” Cold Spring Harb Perspect Med 1, no. 1 (September 2001): 1-15. Accessed 19 June 2018. http://perspectivesinmedicine.cshlp.org/content/1/1/a008862.full
Extent
1 folder
Language of Materials
French
Physical Location
Small collections
Processing Information
This collection was discovered during a survey in the summer and fall of 2015. It was processed in the spring of 2018.
- Title
- Parkinson's Disease prescription
- Author
- Chrissie Perella
- Date
- 19 June 2018
- Description rules
- Describing Archives: A Content Standard
- Language of description
- Undetermined
- Script of description
- Code for undetermined script
Repository Details
Part of the Historical Medical Library of The College of Physicians of Philadelphia Repository
